Frankel SK, Sullivan EJ, Brown KK. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Crit Care Clin. 2002 Oct;18(4):855-79.
Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. Update in the diagnosis and management of pulmonary vasculitis. Chest. 2006 Feb;129(2):452-65.
Flieder DB, Travis WD. Pathologic characteristics of drug-induced lung disease. Clin Chest Med. 2004 Mar;25(1):37-45.
Rossi SE et al. “Crazy Paving” Pattern at thin-section CT of the lungs: Radiologic-pathologic overview. Radiographics 2003; 23(6):1509-1519.
Trapnell BC, Whitsett JA, Nakata K. Pulmonary Alveolar Proteinosis. New England Journal of Medicine 2003; 349(26):2527-2539.
Seymour JF and Presneill JJ. Pulmonary Alveolar Proteinosis: Progress in the first 44 years. Am J Respir Crit Care Med 2002; 166:215-235.
Presneill JJ et al. Pulmonary Alveolar Proteinosis. Clinics in Chest Medicine 2004; 25:593-613.
Beccaria M et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. European Respiratory Journal 2004; 23: 526-531.
Seymour JF et al. Therapeutic Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Idiopathic Acquired Alveolar Proteinosis. Am J Respir Crit Care Med 2001; 163:524-531.
Kavuru MS et al. Exogenous Granulocyte-Macrophage Colony-Stimulating Factor Administration for Pulmonary Alveolar Proteinosis. Am J Respir Crit Care Med 2000; 161:1143-1148.
Venkateshiah, SB et al. An Open-Label Trial of Granulocyte Macrophage Colony Stimulating Factor Therapy for Moderate Symptomatic Pulmonary Alveolar Proteinosis. Chest 2006; 130(1):227-237.
Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1423-38.
Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore). 1996 Nov;75(6):334-42.